JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 178 filers reported holding JUNO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.38 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,284,000 | -19.7% | 115,600 | -21.2% | 0.01% | -23.1% |
| Q3 2017 | $6,581,000 | +37.1% | 146,700 | -8.7% | 0.01% | +18.2% |
| Q2 2017 | $4,800,000 | +129.1% | 160,600 | +70.1% | 0.01% | +120.0% |
| Q1 2017 | $2,095,000 | +148.5% | 94,400 | +111.2% | 0.01% | +66.7% |
| Q4 2016 | $843,000 | +29.5% | 44,700 | +106.0% | 0.00% | +50.0% |
| Q3 2016 | $651,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|